The L1624Q Variant in SCN1A Causes Familial Epilepsy Through a Mixed Gain and Loss of Channel Function
Variants of the SCN1A gene encoding the neuronal voltage-gated sodium channel NaV1.1 cause over 85% of all cases of Dravet syndrome, a severe and often pharmacoresistent epileptic encephalopathy with mostly infantile onset. But with the increased availability of genetic testing for patients with epi...
Main Authors: | Laura B. Jones, Colin H. Peters, Richard E. Rosch, Maxine Owers, Elaine Hughes, Deb K. Pal, Peter C. Ruben |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.788192/full |
Similar Items
-
Effect of Flecainide on Multifocal Ectopic Purkinje-Related Premature Contractions in an R814W SCN5A Carrier
by: Hisham Ahamed, MD, DM, et al.
Published: (2024-03-01) -
Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome
by: Anastasia K. Zaytseva, et al.
Published: (2022-07-01) -
A novel functional variant residing outside the SCN5A-encoded Nav1.5 voltage-sensing domain causes multifocal ectopic Purkinje-related premature contractions
by: Xiaozhi Gao, BS, et al.
Published: (2022-01-01) -
Progressive atrial myocardial fibrosis in a 4-year-old girl with atrial standstill associated with an SCN5A gene mutation
by: Yoshiaki Kato, MD, PhD, et al.
Published: (2022-09-01) -
SCN5A Variants: Association With Cardiac Disorders
by: Wenjia Li, et al.
Published: (2018-10-01)